Target coverage and local recurrences after radiotherapy for sinonasal cancer in Denmark 2008–2015. A DAHANCA study

References

• Cardesa A, Alos L, Nadal A, et al. Nasal cavity and paranasal sinuses. In: Pathology of the head and neck. 2nd ed. Springer, 2017, p. 49–127. ISBN:978-3-662-49672-5
   Google Scholar
• Thorup C, Sebbesen L, Danø H, et al. Carcinoma of the nasal cavity and paranasal sinuses in Denmark 1995-2004. Acta Oncol. 2010;49(3):389–394.
   PubMed Web of Science ®Google Scholar
• Filtenborg MV, Lilja-Fischer JK, Sharma MB, et al. Sinonasal cancer in Denmark 2008-2015: a population-based phase-4 cohort study from DAHANCA. Acta Oncol. 2021;60(3):333–342.
   PubMed Web of Science ®Google Scholar
• Sharma MB, Jensen K, Urbak SF, et al. A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer. Radiother Oncol. 2020;151:58–65.
   PubMed Web of Science ®Google Scholar
• Sharma MB, Jensen K, Amidi A, et al. Late toxicity in the brain after radiotherapy for sinonasal cancer: Neurocognitive functioning, MRI of the brain and quality of life. Clin Transl Radiat Oncol. 2020;25:52–60.
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, Monserez D, Van Rooij P, et al. Highly-conformal intensity-modulated radiotherapy reduced toxicity without jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (chemo)radiation. Oral Oncol. 2012;48(9):905–911.
   PubMed Web of Science ®Google Scholar
• Mock U, Georg D, Bogner J, et al. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys. 2004;58(1):147–154.
   PubMed Web of Science ®Google Scholar
• Grégoire V, Mackie TR. State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report no. 83). Cancer Radiother. 2011;15(6-7):555–559.
   PubMed Web of Science ®Google Scholar
• Menzel HG. The international commission on radiation units and measurements. J Icru. 2010;10(1):1–106.
   Google Scholar
• Overgaard J, Jovanovic A, Godballe C, et al. The Danish head and neck cancer database. Clin Epidemiol. 2016;8:491–496.
   PubMed Web of Science ®Google Scholar
• Von Elm E, STROBE Initiative, Altman D, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349.
   PubMed Web of Science ®Google Scholar
• Jensen K, Friborg J, Hansen CR, et al. The Danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020;151:149–151.
   PubMed Web of Science ®Google Scholar
• Hansen CR, Johansen J, Samsøe E, et al. Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy. Radiother Oncol. 2018;126(1):43–47.
   PubMed Web of Science ®Google Scholar
• Hansen CR, Johansen J, Kristensen CA, et al. Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial. Acta Oncol. 2015;54(9):1669–1673.
   PubMed Web of Science ®Google Scholar
• Brouwer CL, Steenbakkers RJHM, Bourhis J, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG oncology and TROG consensus guidelines. Radiother Oncol. 2015;117(1):83–90.
   PubMed Web of Science ®Google Scholar
• Zukauskaite R, Hansen CR, Brink C, et al. Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods. Acta Oncol. 2017;56(11):1554–1561.
   PubMed Web of Science ®Google Scholar
• Zukauskaite R, Hansen CR, Grau C, et al. Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins. Radiother Oncol. 2018;126(1):48–55.
   PubMed Web of Science ®Google Scholar
• Grau C, Jakobsen MH, Harbo G, et al. Sino-nasal cancer in Denmark 1982-1991–a nationwide survey. Acta Oncol. 2001;40(1):19–23.
   PubMed Web of Science ®Google Scholar
• Schoenfeld G, Amdur R, Morris C, et al. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;71(2):377–385.
   PubMed Web of Science ®Google Scholar
• Dawson L, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46(5):1117–1126.
   PubMed Web of Science ®Google Scholar
• Felice FD, Thomas C, Barrington S, et al. Analysis of loco-regional failures in head and neck cancer after radical radiation therapy. Oral Oncol. 2015;51(11):1051–1055.
   PubMed Web of Science ®Google Scholar
• Shakam A, Scrimger R, Liu D, et al. Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial. Radiother Oncol. 2011;99(2):101–107.
   PubMed Web of Science ®Google Scholar
• Fried DV, Zanation AM, Huang B, et al. Patterns of local failure for sinonasal malignancies. Pract Radiat Oncol. 2013;3:113–120.
   Google Scholar
• Wiegner EA, Daly ME, Murphy JD, et al. Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: Clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys. 2012;83(1):243–251.
   PubMed Web of Science ®Google Scholar
• Due AK, Vogelius IR, Aznar MC, et al. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma. Strahlenther Onkol. 2012;188(8):671–676.
   PubMed Web of Science ®Google Scholar
• Ahn PH, Mitra N, Alonso-Basanta M, et al. Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis. Acta Oncol. 2016;55(9-10):1107–1114.
   PubMed Web of Science ®Google Scholar
• Cantù G, Bimbi G, Miceli R, et al. Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment. Arch Otolaryngol Head Neck Surg. 2008;134(2):170–177.
   PubMedGoogle Scholar
• Dooley L, Shah J. Management of the neck in maxillary sinus carcinomas. Curr Opin Otolaryngol Head Neck Surg. 2015;23(2):107–114.
   PubMed Web of Science ®Google Scholar
• Jégoux F, Métreau A, Louvel G, et al. Paranasal sinus cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130(6):327–325.
   PubMed Web of Science ®Google Scholar